2025 Bronze Sponsor
Christine Zollbrecht
IBA Dosimetry GmbH is a leading provider of integrated and independent Quality Assurance (QA) solutions for Radiation Therapy, Proton Therapy, and Medical Imaging. For over 50 years, IBA Dosimetry has been dedicated to maximizing accuracy, efficiency, and patient safety through innovative products and service.
With the acquisitions of Modus Medical Devices Inc. (branded IBA QUASAR), in 2022 and RADCAL Corporation in 2024, IBA Dosimetry has diversified its portfolio to include advanced tools for MR image guidance, motion management and diagnostic imaging, reinforcing its strong position in the industry.
